WO2007010283A8 - Proteine serine de type beta-lactamase/d-aia carboxypeptidase - Google Patents

Proteine serine de type beta-lactamase/d-aia carboxypeptidase

Info

Publication number
WO2007010283A8
WO2007010283A8 PCT/GB2006/002747 GB2006002747W WO2007010283A8 WO 2007010283 A8 WO2007010283 A8 WO 2007010283A8 GB 2006002747 W GB2006002747 W GB 2006002747W WO 2007010283 A8 WO2007010283 A8 WO 2007010283A8
Authority
WO
WIPO (PCT)
Prior art keywords
protein
lactamase
serine beta
ala carboxypeptidase
carboxypeptidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2006/002747
Other languages
English (en)
Other versions
WO2007010283A1 (fr
Inventor
Richard James Mitter
Richard Joseph Fagan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Trading SA
Original Assignee
Ares Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SA filed Critical Ares Trading SA
Priority to EP06765075A priority Critical patent/EP1913137A1/fr
Publication of WO2007010283A1 publication Critical patent/WO2007010283A1/fr
Anticipated expiration legal-status Critical
Publication of WO2007010283A8 publication Critical patent/WO2007010283A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne une nouvelle protéine, désignée sous le nom de INSP 138, identifiée comme nouvel élément humain de la famille des protéines sérines de type bêta-lactamase/D-AIa carboxypeptidase, et l'utilisation de ladite protéine et des séquences d'acides nucléiques du gène de codage dans le diagnostic, la prévention et le traitement d'une maladie.
PCT/GB2006/002747 2005-07-22 2006-07-24 Proteine serine de type beta-lactamase/d-aia carboxypeptidase Ceased WO2007010283A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06765075A EP1913137A1 (fr) 2005-07-22 2006-07-24 Protéine sérine de type beta-lactamase/d-aia carboxypeptidase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0515180.8 2005-07-22
GB0515180A GB0515180D0 (en) 2005-07-22 2005-07-22 Protein

Publications (2)

Publication Number Publication Date
WO2007010283A1 WO2007010283A1 (fr) 2007-01-25
WO2007010283A8 true WO2007010283A8 (fr) 2008-02-14

Family

ID=34976477

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/002747 Ceased WO2007010283A1 (fr) 2005-07-22 2006-07-24 Proteine serine de type beta-lactamase/d-aia carboxypeptidase

Country Status (3)

Country Link
EP (1) EP1913137A1 (fr)
GB (1) GB0515180D0 (fr)
WO (1) WO2007010283A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3087801A (en) * 2000-02-04 2001-08-14 Molecular Dynamics Inc Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US20030194704A1 (en) * 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two

Also Published As

Publication number Publication date
EP1913137A1 (fr) 2008-04-23
GB0515180D0 (en) 2005-08-31
WO2007010283A1 (fr) 2007-01-25

Similar Documents

Publication Publication Date Title
WO2003054012A3 (fr) Leptines
WO2008015380A3 (fr) Protéine membranaire intégrale
IL169367A0 (en) Defensin proteins
WO2006046073A3 (fr) Proteine du type c1q
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
WO2007010283A8 (fr) Proteine serine de type beta-lactamase/d-aia carboxypeptidase
WO2006016172A3 (fr) Glycoproteine de surface
WO2004053117A3 (fr) Serine protease
WO2003044047A3 (fr) Genes de virulence, proteines, et leurs utilisations
WO2006043060A3 (fr) Proteine contenant le domaine mam
WO2004056983A3 (fr) Proteines de metalloprotease
WO2002070563A3 (fr) Domaine de liaison de ligand au recepteur hormonal nucleaire
WO2004050703A8 (fr) Variant d'epissage de l'hormone de croissance hypophysaire humaine
WO2002029023A8 (fr) Proteine appelee nicastrine
WO2007049062A3 (fr) Protéines contenant des domaines vwfa
GB0613470D0 (en) Protein
WO2005080425A3 (fr) Proteine contenant une sequence nucleotidique repetee riche en leucine
WO2006051333A3 (fr) Proteines contenant des motifs repetes riches en leucine (lrr)
WO2003066844A3 (fr) Proteine p450 cytochrome
WO2008003925A3 (fr) Protéine du complément
WO2002088341A3 (fr) Proteines p450
WO2004016654A8 (fr) Proteine du type il-8
WO2004024762A3 (fr) Proteine de type il-8
WO2004041861A3 (fr) Element de la famille des alpha macroglobulines
WO2004081170A3 (fr) Proteine de type recepteur de la progestine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2006765075

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2006765075

Country of ref document: EP